摘要 |
New imidazo [1,2-c] quinazoline compounds useful as coronary smooth muscle relaxants and corresponding to the formula: <IMAGE> in which: Y is oxygen or sulfur; R1 is (C1-C6) alkyl optionally substituted by a phenyl itself optionally substituted, a (C3-C6) cycloalkyl, optionally substituted phenyl, furyl, thienyl or acyl; R2 is hydrogen, a halogen or a (C1-C6) alkyl optionally substituted by amino or dialkylamino; R3 is hydrogen, (C1-C6) alkyl optionally substituted by an aryl, or R-CO-(CH2)n- [n being 1, 2 or 3, and R being (C1-C6) alkoxy, amino, (alkyl or dialkyl)amino, morpholino or methylpiperazinyl]; and X is hydrogen or a halogen. These compounds and their physiologically tolerated salts can be used in medical treatment of coronary smooth-muscle dysfunctions. |